Perspective of Gene Therapy for Regenerative Medicine: The Future of Complex Disease and Regenerative Application
DOI:
https://doi.org/10.58344/jws.v4i6.1429Keywords:
regenerative medicine, gene delivery, non-viral vectors, viral vectors, tissue engineering, nanoparticlesAbstract
Recent breakthroughs in biotechnology have significantly advanced the potential to regenerate damaged human tissues. Innovations in stem cell science, genetic engineering, and tissue scaffolding have rapidly pushed the boundaries of regenerative medicine. Yet, numerous technical hurdles remain, particularly concerning the clinical application of gene therapy. Core objectives of gene therapy include enhancing protein synthesis within cells, suppressing overactive genes, and rectifying dysfunctional cellular mechanisms linked to disease. While viral vectors remain dominant in current clinical trials due to their effectiveness, they carry risks of immune reactions and pathogenicity. This has sparked increased interest in non-viral alternatives, which promise greater safety and versatility. Non-viral delivery methods utilize plasmid DNA systems and synthetic carriers to transport therapeutic genes and show great potential, especially when integrated with tissue engineering techniques. By combining these non-viral tools with regenerative approaches, researchers aim to more precisely control the spatial and functional behavior of introduced genes within the body. This review critically assesses the evolution and challenges of gene therapy within the broader scope of regenerative medicine, with an emphasis on emerging non-viral delivery systems and their translational promise.
References
a
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Deby Susanti Pada Vinski Vinski, Darren Griffin, Svetlana Trofimova, Natasha Cinta Vinski
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
